What Happened?
New York, NY-based Cellectis Appointed Kyung Nam-Wortman as Executive Vice President and Chief Human Resources Officer
About the Company
Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 20 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells.
About the Person
Kyung Nam-Wortman is Executive Vice President and Chief Human Resources Officer at Cellectis. Previously, Kyung held various senior HR leadership roles in the industry.
Info Source
News
Short Profile